What Is Revolution Medicines, Inc. (RVMD) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Revolution Medicines, Inc.'s intrinsic value is estimated at $41.76, suggesting the stock is overvalued at its current price of $184.44. With 11 out of 12 models flagging downside (-77.4% average return), the market may be pricing in unsustainable growth. Notably, PWERM sees the most upside at -2.4% (fair value: $180.01), while Regime Cross is the most conservative at -99.2% ($1.45). The spread between these extremes — +96.8% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About RVMD?
12 of 13 models are currently active for RVMD. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates RVMD's intrinsic value at $61.95, implying -66.4% downside from the current price. See which stocks rank higher →
How Does RVMD Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, RVMD ranks #68 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Revolution Medicines, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is RVMD a Value Trap?
CirclFi's Value Trap algorithm assigns RVMD a score of 35/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Revolution Medicines, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Revolution Medicines, Inc.'s fundamental quality profile registers 5.2/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +96.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every RVMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across RVMD's 12 active models, average confidence is 29%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad